Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialÉtienne Garin, Lambros Tselikas, Boris Guiu et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 602
Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN InitiativeRobbert S. Puijk, Philippe L. Pereira, Christopher L. Brace et al.|Radiology|2021Cited by 168
Organoids for Functional Precision Medicine in Advanced Pancreatic CancerAlice Boilève, Fanny Jaulin, Jérôme Cartry et al.|Gastroenterology|2024Cited by 83
Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancerJérôme Cartry, Fanny Jaulin, Sabrina Bedja et al.|Journal of Experimental & Clinical Cancer Research|2023Cited by 47
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)Diane Goèré, David Malka, Jean‐Pierre Pignon et al.|BMC Cancer|2018Cited by 46